Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET-A Decade of Post-Authorization Insights.
Jovalekic A, Bullich S, Roé-Vellvé N, Kolinger GD, Howard LR, Elsholz F, Lagos-Quintana M, Blanco-Rodriguez B, Pérez-Martínez E, Gismondi R, Perrotin A, Chapleau M, Keegan R, Mueller A, Stephens AW, Koglin N. Jovalekic A, et al. Among authors: gismondi r. Pharmaceuticals (Basel). 2024 Dec 7;17(12):1648. doi: 10.3390/ph17121648. Pharmaceuticals (Basel). 2024. PMID: 39770490 Free PMC article. Review.
Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study.
Collij LE, Bischof GN, Altomare D, Bader I, Battle M, Vállez García D, Lopes Alves I, Wolz R, Gismondi R, Stephens A, Walker Z, Scheltens P, Nordberg A, Gispert JD, Drzezga A, Perissinotti A, Morbelli S, Buckley C, Garibotto V, Frisoni GB, Farrar G, Barkhof F; AMYPAD Consortium. Collij LE, et al. Among authors: gismondi r. J Nucl Med. 2025 Jan 3;66(1):110-116. doi: 10.2967/jnumed.124.268119. J Nucl Med. 2025. PMID: 39542700 Free PMC article.
Efficacy and safety of trifluridine/tipiracil plus bevacizumab across different subgroups of patients with refractory colorectal cancer: a meta-analysis.
da Silva LFL, Saldanha EF, da Conceição LD, de Andrade Martins W, Gismondi RA, de Souza Filho EM, Peixoto RD. da Silva LFL, et al. Among authors: gismondi ra. Ecancermedicalscience. 2024 Jul 10;18:1728. doi: 10.3332/ecancer.2024.1728. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39421178 Free PMC article.
Amyloid-PET imaging predicts functional decline in clinically normal individuals.
Quenon L, Collij LE, Garcia DV, Lopes Alves I, Gérard T, Malotaux V, Huyghe L, Gispert JD, Jessen F, Visser PJ, den Braber A, Ritchie CW, Boada M, Marquié M, Vandenberghe R, Luckett ES, Schöll M, Frisoni GB, Buckley C, Stephens A, Altomare D, Ford L, Birck C, Mett A, Gismondi R, Wolz R, Grootoonk S, Manber R, Shekari M, Lhommel R, Dricot L, Ivanoiu A, Farrar G, Barkhof F, Hanseeuw BJ; AMYPAD Consortium. Quenon L, et al. Among authors: gismondi r. Alzheimers Res Ther. 2024 Jun 17;16(1):130. doi: 10.1186/s13195-024-01494-9. Alzheimers Res Ther. 2024. PMID: 38886831 Free PMC article.
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
Bollack A, Collij LE, García DV, Shekari M, Altomare D, Payoux P, Dubois B, Grau-Rivera O, Boada M, Marquié M, Nordberg A, Walker Z, Scheltens P, Schöll M, Wolz R, Schott JM, Gismondi R, Stephens A, Buckley C, Frisoni GB, Hanseeuw B, Visser PJ, Vandenberghe R, Drzezga A, Yaqub M, Boellaard R, Gispert JD, Markiewicz P, Cash DM, Farrar G, Barkhof F; AMYPAD consortium. Bollack A, et al. Among authors: gismondi r. Alzheimers Dement. 2024 May;20(5):3429-3441. doi: 10.1002/alz.13761. Epub 2024 Apr 4. Alzheimers Dement. 2024. PMID: 38574374 Free PMC article.
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
Hönig M, Altomare D, Caprioglio C, Collij L, Barkhof F, Van Berckel B, Scheltens P, Farrar G, Battle MR, Theis H, Giehl K, Bischof GN, Garibotto V, Molinuevo JLL, Grau-Rivera O, Delrieu J, Payoux P, Demonet JF, Nordberg AK, Savitcheva I, Walker Z, Edison P, Stephens AW, Gismondi R, Jessen F, Buckley CJ, Gispert JD, Frisoni GB, Drzezga A; AMYPAD Consortium. Hönig M, et al. Among authors: gismondi r. Neurology. 2024 Mar 26;102(6):e208053. doi: 10.1212/WNL.0000000000208053. Epub 2024 Feb 20. Neurology. 2024. PMID: 38377442 Free PMC article.
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.
Bader I, Bader I, Lopes Alves I, Vállez García D, Vellas B, Dubois B, Boada M, Marquié M, Altomare D, Scheltens P, Vandenberghe R, Hanseeuw B, Schöll M, Frisoni GB, Jessen F, Nordberg A, Kivipelto M, Ritchie CW, Grau-Rivera O, Molinuevo JL, Ford L, Stephens A, Gismondi R, Gispert JD, Farrar G, Barkhof F, Visser PJ, Collij LE; AMYPAD consortium. Bader I, et al. Among authors: gismondi r. Alzheimers Res Ther. 2023 Nov 2;15(1):189. doi: 10.1186/s13195-023-01332-4. Alzheimers Res Ther. 2023. PMID: 37919783 Free PMC article.
68 results